Palobiofarma closes a €7M round with the participation of Inveready, Sodena and the Promotor team

by Inveready Asset Management

Thanks to the continued support of Inveready and Sodena, Palobiofarma has become the start-up with the broadest clinical pipeline in Spain, financed basically through licensing agreements such as the ...

Read more

Healthcare startups in Catalonia raise €220 million in 2023, despite global context

by Biocat

Venture capital remains the main source of investment for startups and scaleups, with €114 million (52%). This figure is down from the previous year, mainly due to the cautiousness of financial envi...

Read more

BeAble Capital y BBVA Research presentan el primer informe europeo sobre inversión en tecnologías Deep Science

by BeAble Capital

BeAble Capital, gestora de fondos de capital privado especializada en Science Equity: inversión en tecnologías Deep Science en fases pre-seed, seed y early stage, y BBVA Research, todo un referente ...

Read more

King & Wood Mallesons advises Tressis on the launch of its private equity fund Plan Capital Privado Global FCR

by Addleshaw Goddard

Plan Capital Privado Global FCR will invest around 30% in infrastructure funds, with exposure to mature assets providing essential services to local communities. The remaining 70% will be spread acros...

Read more

El capital privado encuentra en Galicia oportunidades de alto valor para invertir en ciencia y tecnología

by Noso Capital

Un centenar de inversores en ciencia y tecnología nacionales analizaron estas oportunidades en la primera sesión de Invertir en Ciencia sí es rentable, que se celebra en la Facultad de Medicina de ...

Read more

Oncostellae, Marina de Empresas e Ignicia, I Premio 'Invertir en ciencia sí es rentable' por su aportación a la innovación e impulsar ecosistemas de emprendimiento

by Noso Capital

La empresa gallega Oncostellae, el programa Ignicia promovido por la Xunta de Galicia y el ecosistema emprendedor Marina de Empresas-Lanzadera, recibieron hoy los premios Invertir en ciencia sí es re...

Read more

ARTHEx Biotech, backed by Columbus Venture Partners, receives IND Clearance from FDA to Initiate the Phase I-IIa ArthemiR™ Trial of ATX-01 for Myotonic Dystrophy Type 1 (DM1)

by Columbus Venture Partners

ARTHEx Biotech has announced that the U.S. Food and Drug Administration (FDA) cleared the Company to initiate the Phase I-IIa ArthemiR™ study of ATX-01 for the treatment of Myotonic Dystrophy Type 1...

Read more

PBF-999, the first in class treatment in development for the Prader-Willi Syndrome has received 'Orphan Drug Designation' by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA)

by Inveready Asset Management

Palobiofarma S.L., backed by Inveready, is pleased to announce that the FDA and the EMA have granted Orphan Drug Designation to our novel therapeutic candidate, PBF-999, for the treatment of Prader-Wi...

Read more

Invivo Partners is preparing to launch a €100M Invivo Ventures III Fund to invest in Leading-Edge Life Sciences

by Invivo Capital

Invivo Ventures III is strategically designed to propel the emergent field of synthetic biology, a domain where Invivo has already established a formidable presence through investments in pioneering c...

Read more

AbilityPharma announces a €7M investment from a European-Canadian syndicate of life sciences investors, including CTI Life Sciences Fund, Inveready, the EIC Fund, Fitalent and CDTI Innvierte

by Inveready Asset Management

The Catalan biopharmaceutical company Ability Pharmaceuticals, SA (AbilityPharma), focused on the development of innovative oral autophagy-inducing anticancer compounds, announces a €7M investment f...

Read more

Asabys’ portfolio company Cara Care is acquired by Mahana Therapeutics to Become a Global Leader in the Digital Treatment of Digestive Disorders and other Chronic Conditions

by Asabys Partners

Mahana Therapeutics, a leading provider of digital chronic condition management programs, announced today that it has acquired Berlin-based HiDoc Technologies GmbH, operating as Cara Care, a leader in...

Read more

El Gobierno aprueba la creación de la primera sociedad mercantil de terapias avanzadas con capital público-privado de España con la participación del CDTI a través de Innvierte SICC

by CDTI Innovación

El Consejo de Ministros ha aprobado la creación de la primera sociedad mercantil de terapias avanzadas con capital público-privado de España, fruto de un pacto de socios que se formalizará entre e...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Alantra Private Equity strengthens AIVOR...

by Alantra

AIVORIQ has grown significantly since Alantra PE launched the project....

Photos Stream